epidermal growth factor receptor (egfr) mutations
Showing 1 - 2 of 2
NSCLC (NSCLC), Epidermal Growth Factor Receptor (EGFR) Mutations Trial in Beverly Hills, The Woodlands, Fairfax (naquotinib)
Terminated
- Non-small Cell Lung Cancer (NSCLC)
- Epidermal Growth Factor Receptor (EGFR) Mutations
-
Beverly Hills, California
- +2 more
Aug 30, 2018
Epidermal Growth Factor Receptor (EGFR) Mutations, Solid Tumors Trial (radio-labeled naquotinib, naquotinib)
Withdrawn
- Epidermal Growth Factor Receptor (EGFR) Mutations
- Solid Tumors
- radio-labeled naquotinib
- naquotinib
- (no location specified)
Jul 26, 2017